Literature DB >> 10431005

VI. Causes of death in ESRD.

.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10431005     DOI： 10.1053/AJKD034s00087

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  9 in total

Review 1.  Pathogenesis of vascular calcification in dialysis patients.

Authors:  Markus Ketteler; Ralf Westenfeld; Georg Schlieper; Vincent Brandenburg
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

2.  Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.

Authors:  Soochan Bae; Bhargavi Yalamarti; Qingen Ke; Sangita Choudhury; Hyeon Yu; S Ananth Karumanchi; Paul Kroeger; Ravi Thadhani; Peter M Kang
Journal:  Cardiovasc Res       Date:  2011-05-11       Impact factor: 10.787

3.  Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.

Authors:  Ioannis Kourtzelis; Maciej M Markiewski; Michael Doumas; Stavros Rafail; Konstantinos Kambas; Ioannis Mitroulis; Stelios Panagoutsos; Ploumis Passadakis; Vasilios Vargemezis; Paola Magotti; Hongchang Qu; Tom Eirik Mollnes; Konstantinos Ritis; John D Lambris
Journal:  Blood       Date:  2010-04-27       Impact factor: 22.113

4.  Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.

Authors:  Jun H Choi; Qingen Ke; Soochan Bae; Ji Yoo Lee; Yu Jin Kim; Ui Kyoung Kim; Cynthia Arbeeny; Ravi Thadhani; Peter M Kang
Journal:  J Card Fail       Date:  2011-09-09       Impact factor: 5.712

5.  Survival trends of US dialysis patients with heart failure: 1995 to 2005.

Authors:  Austin G Stack; Amir Mohammed; Alan Hanley; Arif Mutwali; Hoang Nguyen
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

Review 6.  The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.

Authors:  Darko Duplancic; Marijan Cesarik; Nikola Kolja Poljak; Maja Radman; Vedran Kovacic; Josipa Radic; Veljko Rogosic
Journal:  Clin Interv Aging       Date:  2013-02-11       Impact factor: 4.458

7.  Decreased Serum 25-hydroxyvitamin D Level Causes Interventricular Septal Hypertrophy in Patients on Peritoneal Dialysis: Cardiovascular Aspects of Endogenous Vitamin D Deficiency.

Authors:  Bennur Esen; Irfan Sahin; Ahmet Engin Atay; Emel Saglam Gokmen; Ozlem Harmankaya Kaptanogullari; Mürvet Yılmaz; Suat Hayri Kucuk; Serdar Kahvecioglu; Nurhan Seyahi
Journal:  Int J Nephrol       Date:  2016-11-27

8.  Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.

Authors:  Santosh A Khedkar; Mohammed A Samad; Sangita Choudhury; Ji Yoo Lee; Dongsheng Zhang; Ravi I Thadhani; S Ananth Karumanchi; Alan C Rigby; Peter M Kang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

9.  Suboptimal medical care of patients with ST-elevation myocardial infarction and renal insufficiency: results from the Korea Acute Myocardial Infarction Registry.

Authors:  Joon Seok Choi; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Myung Ho Jeong; Young Jo Kim; Myeong Chan Cho; Chong Jin Kim; Soo Wan Kim
Journal:  BMC Nephrol       Date:  2012-09-11       Impact factor: 2.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.